Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Triple GLP-1 / GIP / Glucagon Receptor Agonist (CAS 2381089-83-2) Compound Name: Research Peptide (CAS 2381089-83-2) Classification: Research Peptide Multi-Receptor Agonist Description: This compound is a synthetic research peptide that functions as a triple agonist of the glucagon receptor (GCGR), glucose dependent insulinotropic polypeptide receptor (GIPR), and glucagon like peptide-1 receptor (GLP-1R)
This multi-receptor mechanism distinguishes it from earlier agents such as semaglutide and tirzepatide
[PMID: 26476010] PubMed record related to this compound for laboratory literature review
using individual (eta) values for CL to identify differences across subjects for Q , as well as for V c and V p
Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study
Acid-reducing medications such as proton pump inhibitors (PPIs) like omeprazole or H2 blockers like famotidine may benefit patients who experience nausea accompanied by acid reflux or heartburn
US$ 29.96
US$ 23.62
US$ 22.81
US$ 20.06
US$ 20.85
US$ 22.88
US$ 26.39
US$ 29.07
US$ 29.28
US$ 27.41
US$ 28.07
